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Previous investigations have resulted in con-
flicting data on the relationship between psoriasis
and blood uric acid levels. Some workers have
reported a high incidence of hyperuricemia in
psoriasis, while others found normal values in a
high percentage of the cases studied. Sehambcrg
and coworkers (1) found that only 4 out of 15
psoriatie patients studied had elevated blood
uric acid levels. These workers attribute the 4
eases of hyperurieemia to the co-existence of
abnormal renal function. In contrast to these
results, Coultre (2), in a study of 10 psoriatic
patients, reported elevated blood uric acid levels
in every ease.
Lobitz and Brunsting (3) found a relatively
high percentage of hyperuricemia in patients
hospitalized with severe psoriasis. Psoriaties
studied without regard to the severity of the
disease showed elevations in only 15 per cent of
the cases investigated. Recently, Steinberg et at.
(4), reporting the results of serum uric acid
determinations on 177 psoriatic patients, found
that 48 per cent of the males and 27 per cent of
the females showed hyperurieemia.
Three groups of factors known to influence
blood uric acid levels might explain these diver-
gent results. They are: (1) the existence of
certain pathological conditions, other than
psoriasis, (2) the influence of various medica-
tions, and (3) the chemical methods used in the
uric acid analysis.
Included in the first group arc kidney and
liver dysfunction, blood dyscrasias, febrile in-
fections, pregnancy, gout, familial hyperuricemia,
malignancies, inanition, ketosis, and obesity.
In the second group are medications known to
influence blood uric acid concentrations. This
group includes salicylates, ACTH, and cortisone,
all of which tend to depress an already elevated
blood uric acid if given in sufficiently large dosage.
Thirdly, the validity of any chemical procedure
is limited by its degree of specificity. Neither
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the direct nor the indirect color reactions com-
monly used are specific for uric acid. In evaluat-
ing data on blood uric acid concentrations in
any disease state, a highly specific method for
the determination of uric acid is essential.
The purpose of the present investigation is to
determine whether psoriasis or other dermatoses
are accompanied by hyperuricemia, and, if so,
whether there is any correlation between the
extent and duration of the disease and the degree
of uric acid elevation. In carrying out this study,
we have controlled the subjects with respect to
pertinent pathological and therapeutic factors,
and have employed an enzymatic method specific
for determining uric acid.
PROCEDURE
Two groups of patients were studied, one
group consisting of 48 patients with psoriasis,
the second (control) group consisting of 48 pa-
tients with other dermatoses. The non-psoriatic
dermatoscs consisted of atopic dermatitis,
neurodermatitis, contact dermatitis, infectious
eczematoid dermatitis, and a miscellaneous
group including dermatitis herpetiformis, sebor-
rheic dermatitis, pemphigus, lichen planus,
mycosis fungoides, nrticaria, vasomotor in-
stability, moniliasis, and keratodcrma of palms
and soles.
Complete histories were taken on all patients
of both groups, with special reference to family
history of gout or other metabolic disorders, and
to duration of lesions. Complete physical exami-
nations were done, and the type and extent of
lesions, and presence or absence of gouty tophi
particularly noted. Wherever necessary, skin
biopsies were performed to confirm the diagnosis.
All patients had complete blood counts, urin-
alyses, and renal function tests consisting of
blood non-protein nitrogen, serum creatinine
determination, and creatininc clearance test.
The following liver function tests were carried
out: serum protein determination, ecphalin
flocculation, thymol turbidity, thymol floccula-
tion, and serum bilirubin determination.
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CHEMICAL METHODS
Uric acid was determined on lasting bloods
within one hour alter collection. Three methods
of analysis were used: the direct method of
Folin (5), the indirect method of Newton (6),
and the enzymatic method of Block and Geib (7).
Folin's procedure (5) involves addition of the
color reagents directly to a deproteinized blood
filtrate, in addition to uric acid, this procedure
also measures non-uric acid ehromogens present
in whole blood, and therefore lacks specificity.
The method is further complicated by the fact
that whole blood filtrates also contain substances
which tend to depress the color produced by
uric acid itself. (7).
In the indirect procedure of Newton (6),
interfering substances (e. g. ergothioneine and
glutathione) arc removed by precipitation as
silver salts from a deproteinized whole blood
filtrate. The insoluble silver salts are removed by
centrifugation, and color reagents added to an
aliquot of the supernatant. Newton's method (6),
while more specific than the direct procedure,
still measures other non-uric acid ehromogens,
and therefore lacks complete specificity.
The method of Block and Geib (7), is based
on the oxidation of uric acid (chromogenic) to
allantoin (non-ehromogenie) by the specific
enzyme unease. Interference by ergothioneine
and glutathione is eliminated as described under
the indirect procedure. Following removal of
these interfering substances, total color is meas-
ured. This total color corresponds to the uric
acid value obtained by the Newton procedure.
To another aliquot of the blood sample, a suitable
amount of the enzyme uricase is added, the
mixture incubated, and the color remaining after
incubation is measured. This value, called residual
color, represents the contribution to the total
color of non-uric acid chromogens. The difference
between total color and residual color represents
the amount of ehromogen destroyed by unease.
By virtue of the specificity of the enzyme, this
chromogen should only be uric acid. This cal-
culated difference is referred to as the so-called
"true" uric acid value.
In the discussion following, values higher than
4.6 mg. per cent are considered elevated when
uric acid is determined by the enzymatic method.
The corresponding figure for the direct procedure
is 4.0 mg. per cent, and for the indirect pro-
cedure 5.0 mg. per cent.
nE5ULT5
In Table I are hsted whole blood uric acid
values, as determined by the three methods
previously described, on 48 patients with psonia-
sis. These patients are divided into 4 groups,
depending on the extent of lesions.
The first group (few lesions) included 7 pa-
tients (4 males and 3 females) ranging in age
from 25 to 71 years. Six of these patients had
the disease for 10 years, the seventh for 1 year.
One patient (F. R. F.) was obese, and was found
to have abnormal liver and kidney function,
with an elevated non-protein nitrogen (50 mg.
per cent). Results of the uric acid determina-
tions obtained by the enzymatic procedure
showed normal values in 6 eases, only 1 patient
(F. II. F.) showing an elevation. By the direct
method, 6 of the 7 patients showed blood uric
acid elevations. Results obtained by the indirect
procedure parallel those obtained by the enzy-
matic method, with 1 patient (F. R. F.) showing
evidence of hyperuricemia.
The second group (moderate number of
lesions) was composed of 33 patients (19 females
and 14 males) ranging in age from 16 to 78 years.
The duration of disease varied between 1 and 10
years. Ten of these patients were obese. Three
eases (H. E. H.,G. L.O.,J. A. N.) showed abnormal
liver function. All patients in this group had
normal renal function. Of the 33 patients com-
prising this group, 3 (A. M. E.,J. A. N., M. U. I.)
showed evidence of hyperuricemia by the enzy-
matic procedure. By the direct procedure, 26
of the 33 patients studied showed evidence of
hyperurieemia. Results obtained using the
indirect procedure again paralleled those ob-
tained by the enzymatic method, with the same
three patients showing uric acid elevations.
The third group (generalized lesions) included
only 3 patients, 1 male and 2 females. Ages
ranged from 17 to 81 years, and the duration
of the disease from 2 to 10 years. Two of these
patients were obese, and one, patient B. A. R.,
showed an abnormal renal function with a non-
protein nitrogen between 46 and 56 ing. per cent
on repeated determinations. Two patients
(D. 0. F., B. A. R.) gave evidence of hyper-
urieemia by the enzymatic procedure. By the
direct method, all 3 patients showed elevated
uric acid levels. The indirect procedure again
gave values corresponding to those obtained
by the enzymatic procedure.
TABLE I
A comparison of uric acid levels in whole blood by direcl, indirect and enzymatic methods in
patients with psoriasis
Uric Acid
A DurationExtent of Lesions Patient Sex ge Body Size of Disease Directears years Total Total Residual True
M mg. mg. mg.Per lilt per cent per cent per cent
Minimal B. R. 0. M 25 Medium 1 5.25 4.27 0.51 3.76
L. A. S. F 34 Thin 10 4.40 3.64 0.65 2.99
L. Y. N. F 52 Medium 10 3.41 2.81 0.50 2.31
F. R. E. F 65 Obese 10 7.67 6.23 0.67 5.56
B. A. K. M 45 Medium 10 4.08 3.43 0.45 2.98
C. 0. N. M 53 Thin 10 3.89 2.98 0.51 2.47
W. A. C. M 71 Medium 10 3.59 0.48 3.11
Moderate T. R. I. F 16 Thin 1 3.53 2.94 0.45 2.49
M. U. I. F 31 Obese 2 7.93 5.52 0.55 4.87
J. A. S. M 22 Medium 2 5.13 4.43 0.61 3.82
A. M. E. M 36 Obese 3 8.09 6.09 0.55 5.54
H. A. M. F 22 Medium 4 3.21 2.83 0.56 2.27
J. E. N. F 57 Obese 4 4.96 3.87 0.55 3.32
H. E. H. F 60 Obese 4 4.27 3.27 0.61 2.66
E. Z. E. F 20 Medium 5 3.11 2.73 0.43 2.30
S. T. E. F 36 Medium 5 5.96 4.73 0.52 4.21
D. I. B. M 27 Medium 5 4.81 4.01 0.46 3.55
M. C. L. M 62 Thin 5 4.47 3.31 0.55 2.76
V. E. L. F 20 Medium 8 4.99 3.81 0.52 3.29
B. 0. W. F 24 Medium 10 4.63 4.06 0.51 3.55
H. A. N. F 50 Medium 10 2.63 2.10 0.54 1.56
C. A. R. F 51 Obese 10 4.42 0.47 3.75
K. U. N. F 55 Obese 10 6.15 4.48 0.67 3.81
B. A. I. F 58 Medium 10 5.78 4.47 0.58 3.89
G. A. G. F 62 Obese 10 4.33 3.39 0.54 2.85
B. U. R. F 64 Medium 10 4.18 3.06 0.59 2.47
Z. E. M. F 65 Obese 10 5.78 4.51 0.61 3.90
M. A. G. F 70 Medium 10 3.08 2.59 0.50 2.09
C. H. A. F 71 Medium 10 5.24 4.26 0.61 3.65
G. L. 0. F 78 Medium 10 4.56 3.97 0.63 3.34
W. I. T. M 18 Medium 10 5.51 4.32 0.38 3.94
G. 0. R. M 31 Medium 10 5.62 4.12 0.37 3.75
R. E. V. M 34 Medium 10 5.77 4.57 0.55 4.02
J. A. N. M 39 Obese 10 8.96 7.65 0.45 7.20
W. A. L. M 40 Medium 10 5.40 4.36 0.48 3.88
S. A. V. M 41 Medium 10 4.12 2.85 0.47 2.38
B. E. L. M 51 Medium 10 4.05 3.35 0.47 2.88
D. H. U. M 65 Thin 10 4.08 3.45 0.51 2.94
S. T. E. M 71 Obese 10 4.65 3.98 0.48 3.50
T. 0. M. M 45 Medium 10 6.47 4.71 0.56 4.15
Generalized H. 0. R. F 17 Medium 2 4.47 3.49 0.41 3.08
D. 0. E. F 57 Obese 6 6.88 6.03 0.65 5.38
B. A. R. M 81 Obese 10 7.12 0.54 6.58
Universal A. R. D. M 51 Obese 4 7.08 6.35 0.38 5.97
N. I. C. M 44 Medium 5 6.77 0.69 6.08
P. A. R. F 68 Medium 10 5.80 4.27 0.55 3.72
0. T. I. M 45 Obese 10 8.18 6.86 0.61 6.25
M. A. T. M 47 Obese 10 7.41 6.63 0.61 6.02
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The fourth group (universal psoriasis) included
5 patients, 4 males and 1 female. These patients
ranged in age from 44 to 68 years, with lesions
varying in duration from 4 to 10 years. Three
of these patients were obese, and one, (M. A. T.)
had abnormal liver function. This patient gave
a history of chronic alcoholism. Patient N. I. C.
had severe rheumatoid arthritis, with anorexia,
weight loss and fever. Four patients in this
group (A. R. D., N. I. C., 0. T. I., M. A. T.)
showed elevated blood uric acid levels. By the
direct procedure, all patients in this group
showed elevated blood uric acid levels. By the
indirect procedure, results comparable to those
by the enzymatic procedure were again ob-
tained.
In Table II are recorded the uric acid values
on a control group of 48 patients with dermatoses
other than psoriasis. These are divided into 5
groups, which include atopie dermatitis, neuro-
dermatitis disseminata, contact dermatitis with
superimposed neurodermatitis, infectious ecze-
matoid dermatitis, and a miscellaneous group
of other dermatoses.
The 6 patients comprising the group with
atopie dermatitis included 4 males and 2 females,
whose ages range from 18 to 29 years. The
duration of disease varied between 3 and 25
years, 4 eases being recurrent. The extent of
lesions was generalized in 4 eases and moderate
in 2 eases. All of these patients had normal
liver and renal function, and none were obese.
Two patients in this group (V. I. S., A. B. E.)
showed uric acid elevations by both the enzy-
matic and indirect procedures. Five patients
showed elevations, however, using the direct
procedure.
In the group with neurodermatitis dissemi-
nata, there were 9 patients, 8 males and 1 female,
whose ages ranged between 41 and 72 years.
The duration of disease varied from 3 months
to 20 years. The 3 cases with duration of disease
10 years or longer were all recurrent. Two pa-
tients in this group were obese. All had normal
renal and liver function. Results of the uric
acid determinations by the enzymatic procedure
showed 1 patient (T. A. Y.) with an elevation.
By the indirect procedure, 2 patients, (T. A. Y.,
D. I. E.) showed elevation. Five of the 8 patients
studied by the direct procedure showed eleva-
tions.
The group of 7 patients with contact dermatitis
and superimposed neurodermatitis included 3
females and 4 males, whose ages ranged between
18 and 61 years. The disease varied in duration
from 6 months to 13 years, with 4 cases showing
recurring lesions. Three of these 7 patients were
obese, but all showed normal liver and kidney
function. Two patients (S. A. Y., B. 0. L.) showed
elevation in blood uric acid by both the enzy-
matic and indirect procedures. Considering
values obtained by the direct procedure, this
number was increased to five.
The group of 10 patients with infectious
eczematoid dermatitis included 9 males and 1
female, with ages ranging from 21 to 79 years.
The duration of disease varied between 1 month
and 10 years, with 2 recurrent eases. Two of
these patients were obese, and 1 patient
(M. E. Y.) had abnormal renal function, with
an elevated blood non-protein nitrogen (50 mg.
per cent). All patients in this group had normal
liver function. Results of the uric acid determina-
tions showed 6 eases of the 10 studied with ele-
vated uric acid levels, by the enzymatic proce-
dure. Results by the indirect procedure are
comparable. By the direct procedure, however,
of the 9 patients studied, all showed elevated uric
acid levels.
The miscellaneous group included 16 patients,
8 males and 8 females. Diagnoses are listed in
Table II. These patients ranged in age from 17
to 75 years, with lesions varying in duration from
1 month to 40 years. Patient M. E. R. had a
severe and painful moniliasis of the mouth, with
considerably reduced food intake. He showed
some liver dysfunction, with a +4 eephalin floc-
culation and a slightly elevated thymol turbidity.
Patient T. A. 'V., with severe dermatitis herpeti-
formis, had a severe anorexia amounting to star-
vation, with extreme weight loss. This patient
also had pernicious anemia. Three patients in this
group were obese. Of the 16 patients comprising
this group, only 3 showed elevated uric acid levels
by either the enzymatic or the indirect proce-
dures. Fourteen patients showed elevations, how-
ever, using the direct procedure.
Considering the 48 patients with dermatoses
other than psoriasis as a single group, there were
14 cases with elevated blood uric acid levels, when
the enzymatic procedure was employed for the
determination. 13y the indirect procedure, there
were 15 eases with hyperuricemia; by the direct
procedure, 38 eases.
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t N. I. C—Rheumatoid arthritis, anorexia, fever.
T. A. Y.—Pernicious anemia, anorexia, starvation.
§ M. E. R.—Reduced food intake.
In Table III are listed all patients of both
groups found to bave elevated uric acid levels,
together with pertinent information concerning
coexistent pathological conditions, obesity, and
extent of lcsions.
DISCUSSION
The uric acid values given in Tables I and II
show that the method used for the estimation of
uric acid in blood influences the results obtained.
Thus, Folin's direct procedure shows hyperuri-
cemia in 38 eases of the 45 psoriaties studied, and
in 38 eases of the 45 patients with dermatoses
other than psoriasis. Results obtained by the
enzymatic procedure on the same patients show
10 eases with elevations in the group of psoriatics,
14 in the patients with other dermatoses. Results
by the indirect procedure of Newton are practi-
cally identical with those by the enzymatic proce-
dure, with 10 elevations among the psoriatic
TABLE III
Correlation of elevated blood uric acid levels with various pathological conditions in patients
with psoriasis and other dermatoses
Diagnosis Patient Estent ofLesions
Duration
of ?5e
True Uric
Acid
Mg.
Per Cent
Body Size LiverFunction I KidneyFunction
Psoriasis
Other dermatoses
Atopic dermatitis
Neurodermatitis
disseminata
Contact dermatitis
and superimposed
neurodermatitis
Infectious ecze-
matoid dermatitis
Dermatitis herpeti-
formis
Moniliasis
Vasomotor insta-
bility
F. R. E.
M. U. I.
A. M. E.
J. A. N.
D.O.E.
B. A. R.
A. 11. D.
N. I. C.t
0. T. I.
M. A. T.
V.1.8.
A. B. E.
T. A. X.
S. A. Y.
B. 0. L.
A. N. D.
M. E. Y.
R. 11.0.
PT. E.
S. T. R.
S. C. 11.
T. A. Y.t
M. E. R.
K. R. E.
Minimal
Moderate
Moderate
Moderate
Generalized
Generalized
Universal
Universal
Universal
Universal
Moderate
Generalized
Universal
Arms and
hands
Arms and
hands
Moderate
Generalized
Generalized
Generalized
Generalized
Generalized
nummular
Generalized
Mouth and
pharynx
Obese
Obese
Obese
Obese
Obese
Obese
Obese
Medium
Obese
Obese
Medium
Medium
Obese
Obese
Obese
Obese
Medium
Medium
Medium
Obese
Medium
10
2
3
10
6
10
4
5
10
10
6*
S
34
2*
2*
1//2
312
34
:1
1*
312
2
312
Abnormal
Normal
Normal
Abnormal
Normal
Normal
Normal
Normal
Normal
Abnormal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
5.56
4.87
5.54
7.20
5.38
6.58
5.97
6.08
6.25
6.02
5.16
5.10
6.66
6.12
4.90
4.77
5.10
6.35
4.72
5.21
4.66
5.27
6.09
5.15
Abnormal
Normal
Normal
Normal
Normal
Abnormal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Abnormal
Normal
Normal
Normal
Normal
NormalMedium Normal
* Recurrent.
Medium Abnormal Normal
Medium Normal Normal
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patients, 15 in the group of patients having
dermatoses other than psoriasis. These findings
are consistent with the facts already mentioned
that Folin's direct procedure is not specific for
uric acid, and that the indirect procedure of
Newton, while not completely specific, gives a
more valid measure of the uric acid content. The
enzymatic procedure is highly specific, if sub-
stances which influence the intensity of the color
developed by uric acid are first removed. It would
seem probable that the divergent results previ-
ously obtained concerning the relationship be-
tween hyperurieemia and psoriasis may be
partially explained by differences in the method
used for determining uric acid. In the discussion
following, all figures given refer to values obtained
by the enzymatic procedure.
From the group of 48 psoriatic patients studied,
there were 10 patients with elevated blood uric
acid levels. This value for the incidence of hyper-
urieemia is psoriasis (approximately 20 per cent)
agrees well with results obtained by Sehamberg
(1), but is considerably lower than results re-
ported by other workers (2, 3, 4). As indicated in
Table III, however, 5 of these 10 elevations can
be related to other pathological conditions known
to produce hyperurieemia. Patients J. A. N. and
M. A. T. had abnormal liver function, and pa-
tient F. R. E. had both kidney and liver dysfunc-
tion. (In this connection, it should be noted that
2 psoriatie patients, H. F. H. and G. L. 0., hav-
ing abnormal kidney function gave no evidence
of hyperurieemia). Patient N. I. C. had severe
rheumatoid arthritis, with anorexia, weight loss
and fever. This leaves only 5 cases out of the 48
studied whose uric acid elevations have no appar-
ent relation to pathological conditions other than
psoriasis.
In the group of patients with dermatoses other
than psoriasis there were 14 eases with elevated
blood uric acid levels. Of these 14 patients, 1
(M. F. R.) could be related to the coexistence of
abnormal liver function, 1 (M. F. Y.) to abnormal
renal function, and 1 (T. A. Y.) to pernicious
anemia, with associated anorexia, severe enough
to lead to starvation. In the group of 48 patients
with dermatoses other than psoriasis there were,
therefore, 11 instances of uric acid elevations not
related to pathological conditions known to pro-
duce hyperuricemia.
From these results it is evident that the inci-
dence of uric acid elevation in psoriasis is no
higher, if as high, as that of a group of patients
with other dermatoses studied under the same
conditions. These data for uric acid elevation in
both groups (5 out of 48 psoriaties, and 11 out
of 48 patients with other dermatoses) compare
favorably to variations found in normal individ-
uals and in patients with medical conditions not
usually associated with an elevated blood uric
acid. Jordan and Gaston (8), using the Folin
method, found 2 out of 13 normal individuals and
8 out of 54 patients with multiple pathologies had
blood uric acid elevations. Jacobson (9), deter-
mining serum uric acid levels by Folin's method
(5) in 100 non-gouty individuals excluding renal
disease, liver dysfunction and leukemia, found 3
patients having levels over 6 mg. per cent, and
23 patients with levels ranging between 5 and 6
mg. per cent. Stecher, Hersh and Solomon (10),
investigating the heredity of gout and familial
hyperurieemia, studied as controls 961 medical
patients. Thirty-four patients were found to have
elevations. It would, therefore, seem that a small
percentage of elevated blood uric acid levels will
be found in any group.
From these results, there would seem to be no
apparent relationship between hyperurieemia and
psoriasis, considered without regard to the sever-
ity of the disease.
An attempt to correlate the incidence of hyper-
uricemia in psoriasis with the extent of lesions is
limited by the small number of patients in the
groups whose extent of lesions were generalized
or universal. There is some indication, however,
that the incidence of hyperuricemia rises with the
severity of the disease. Thus, of the 40 psoriaties
whose extent of lesions were minimal or general-
ized, there are only 2 eases of uric acid elevation
which cannot be related to other pathological
conditions. Among the 8 patients whose extent
of lesions were generalized or universal, there are
3 eases of uric acid elevation which cannot be
related to other pathological conditions. Since
these latter two groups include such a small num-
ber of patients, no definite conclusions can be
made. On the basis of these data, however, it
would seem likely that, if a relationship does exist
between hyperuricemia and psoriasis, this rela-
tionship is greatly dependent on the extent of the
disease.
When the groups of patients with dermatoses
other than psoriasis are considered individually,
it can be seen from Table II that there is some
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indication that those dermatoses with acute weep-
ing lesions and secondary infection, as found in
infectious eezematoid dermatitis, nummular
eczema and absorption phenomena, show a higher
incidence of blood uric acid elevation than do
other types of dermatoses. The number of pa-
tients is too small, however, to be of statistical
importance. It may also be true that elevations
of blood uric acid in this type of dermatitis may
be due to accompanying fever and tissue break-
down.
Obesity and psoriasis are often associated, and
increase in weight often aggravates psoriatic
lesions. It therefore seemed worthwhile to attempt
to correlate obesity, elevated blood uric acid, and
psoriasis. Sebamberg', stated that there appeared
to be a definite increase of blood uric acid with
rise in weight. It can be seen from Table I that
all the psoriaties, except patient N. I. C. who
showed elevated blood uric acid were obese. This
one exception, already discussed, can be seen
from Table III to be related to anorexia and
fever. Of the 14 patients with dermatoses other
than psoriasis who showed evidence of hyper-
uricemia, five were obese. If the suggestion of
Sehamberg is valid, and obesity can be regarded
as a causative factor in hyperuricemia, there are
no eases of psoriasis with uric acid elevations not
related to other pathological conditions (see
Table III). However, it must be noted that there
were 16 obese individuals in the psoriatie group,
only 9 of which had elevated uric acid levels.
Included in the non-psoriatie group are 10 obese
individuals, 5 of whom had elevated blood uric
acids. On the basis of these experiments, there-
fore, it would seem that the question of a relation-
ship between hyperuricemia and obesity should
be investigated further.
sUMMARY
Forty-eight psoriatie patients and 48 patients
with other dermatoses were investigated with
respect to blood uric acid levels. Five patients in
the psoriatie group, and 11 patients in the group
with other dermatoses showed high uric acid
levels, which could not be related to any patho-
logical condition known to produce hyperuri-
cemia. Our data indicate the possibility of a rela-
tionship between obesity and hyperuricemia.
Since the number of obese individuals studied
was small, however, this question needs further
investigation.
From our data, the incidence of hyperurieemia
in psoriasis is low, in fact lower than the control
group of patients with other dermatoses. It is
therefore concluded that psoriasis is not accom-
panied by abnormal blood uric acid levels.
Conflicting data on blood uric acid levels in
psoriasis previously reported may be partially
explained on the basis of (1) coexistent physio-
logical and pathological conditions, and (2) differ-
ences in the methods used for the uric acid
determinations.
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